Friday, June 12, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1144 of 1,261
  1. US 6815173

    Method for detecting syphilis using synthetic antigents

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Nov 9, 2004 Β· Expires Nov 4, 2024

    expired
  2. US 6815458

    Azacyclic compounds

    ACADIA Pharmaceuticals Inc. Β· Granted Nov 9, 2004 Β· Expires Nov 4, 2024

    expired
  3. US 6815188

    Human kinases and polynucleotides encoding the same

    Lexicon Genetics, Inc. Β· Granted Nov 9, 2004 Β· Expires Nov 4, 2024

    expired
  4. US 6811780

    Methods of using cytokine antagonists to treat HIV infection and AIDS

    REGENERON PHARMACEUTICALS, INC. Β· Granted Nov 2, 2004 Β· Expires Oct 28, 2024

    expired
  5. US 6811787

    Over-expressing homologous antigen vaccine and a method of making the same

    The Regents of the University of California Β· Granted Nov 2, 2004 Β· Expires Oct 28, 2024

    expired
  6. US 6811775

    Reovirus for the treatment of cellular proliferative disorders

    ONCOLYTICS BIOTECH INC. Β· Granted Nov 2, 2004 Β· Expires Oct 28, 2024

    expired
  7. US 6811782

    Peptide composition as immunogen for the treatment of allergy

    United Biomedical, Inc. Β· Granted Nov 2, 2004 Β· Expires Oct 28, 2024

    expired
  8. US 6811776

    Process for ex vivo formation of mammalian bone and uses thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Nov 2, 2004 Β· Expires Oct 28, 2024

    expired
  9. US 6812336

    Transcription factor coactivator protein, p/CIP

    The Regents of the University of California Β· Granted Nov 2, 2004 Β· Expires Oct 28, 2024

    expired
  10. US 6812216

    11-C-substituted derivatives of clarithromycin

    Enanta Pharmaceuticals, Inc. Β· Granted Nov 2, 2004 Β· Expires Oct 28, 2024

    expired
  11. US 6812034

    Fetuin-MGP-mineral complex in serum assayed to determine calcification risk

    The Regents of the University of California Β· Granted Nov 2, 2004 Β· Expires Oct 28, 2024

    expired
  12. US 6812246

    Aminoflavone compounds, compositions, and methods of use thereof

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Nov 2, 2004 Β· Expires Oct 28, 2024

    expired
  13. US 6808707

    Wound healing compositions and methods using tropoelastin and lysyl oxidase

    MATRIX DESIGN GROUP LLC Β· Granted Oct 26, 2004 Β· Expires Oct 21, 2024

    expired
  14. US 6809100

    Hydroxamic acid derivatives

    Darwin Discovery Limited Β· Granted Oct 26, 2004 Β· Expires Oct 21, 2024

    expired
  15. US 6809077

    Cyclosporin analogs for the treatment of autoimmune diseases

    Enanta Pharmaceuticals, Inc. Β· Granted Oct 26, 2004 Β· Expires Oct 21, 2024

    expired
  16. US 6808878

    Genes from the 20Q13 amplicon and their uses

    The Regents of the University of California Β· Granted Oct 26, 2004 Β· Expires Oct 21, 2024

    expired
  17. US 6808916

    Method of extracting virus from cell culture

    ONCOLYTICS BIOTECH INC. Β· Granted Oct 26, 2004 Β· Expires Oct 21, 2024

    expired
  18. US 6808875

    Methods for screening cellular proliferation using isotope labels

    The Regents of the University of California Β· Granted Oct 26, 2004 Β· Expires Oct 21, 2024

    expired
  19. US 6808877

    Ligands for FPR class receptors that induce a host immune response to a pathogen or inhibit HIV infection

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Oct 26, 2004 Β· Expires Oct 21, 2024

    expired
  20. US 6809191

    GM-CSF nucleic acid sequences

    Vaxim, Inc. Β· Granted Oct 26, 2004 Β· Expires Oct 21, 2024

    expired
  21. US 6808702

    Treatment of disorders by implanting stem cells and/or progeny thereof into gastrointestinal organs

    The Board of Regents of the University of Texas System Β· Granted Oct 26, 2004 Β· Expires Oct 21, 2024

    expired
  22. US 6808880

    Method for detecting polynucleotides encoding telomerase

    The Regents of the University of Colorado Β· Granted Oct 26, 2004 Β· Expires Oct 21, 2024

    expired
  23. US 6809184

    Antibodies, including FV molecules, and immunoconjugates having high binding affinity for mesothelin and methods for their use

    The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Oct 26, 2004 Β· Expires Oct 21, 2024

    expired
  24. US 6809075

    Elastin peptide analogs and uses of same incombination with skin enhancing agents

    Connective Tissue Imagineering, LLC Β· Granted Oct 26, 2004 Β· Expires Oct 21, 2024

    expired

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.